New booster shot trial aims to protect against three dangerous diseases
NCT ID NCT07418372
Summary
This study is testing a new version of the Tdap vaccine, which protects against tetanus, diphtheria, and whooping cough (pertussis). Researchers want to see if this vaccine, which contains fewer antigens, is safe and triggers a good immune response in people aged 6 years and older. The trial will involve 660 participants who will be randomly assigned to receive either the new vaccine or a control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiangjin District Center for Disease Control and Prevention
Chongqing, Chongqing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.